- Home
- DXLG vs DTIL Comparison
DXLG vs DTIL Comparison
Compare DXLG & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DXLG
- DTIL
- Stock Information
- Founded
- DXLG 1976
- DTIL 2006
- Country
- DXLG United States
- DTIL United States
- Employees
- DXLG N/A
- DTIL N/A
- Industry
- DXLG Clothing/Shoe/Accessory Stores
- DTIL Biotechnology: Pharmaceutical Preparations
- Sector
- DXLG Consumer Discretionary
- DTIL Health Care
- Exchange
- DXLG Nasdaq
- DTIL Nasdaq
- Market Cap
- DXLG 64.0M
- DTIL 51.6M
- IPO Year
- DXLG 1987
- DTIL 2019
- Fundamental
- Price
- DXLG $1.03
- DTIL $4.79
- Analyst Decision
- DXLG Strong Buy
- DTIL Strong Buy
- Analyst Count
- DXLG 1
- DTIL 2
- Target Price
- DXLG $2.50
- DTIL $47.00
- AVG Volume (30 Days)
- DXLG 270.8K
- DTIL 85.2K
- Earning Date
- DXLG 05-29-2025
- DTIL 07-31-2025
- Dividend Yield
- DXLG N/A
- DTIL N/A
- EPS Growth
- DXLG N/A
- DTIL N/A
- EPS
- DXLG N/A
- DTIL N/A
- Revenue
- DXLG $457,059,000.00
- DTIL $51,141,000.00
- Revenue This Year
- DXLG N/A
- DTIL N/A
- Revenue Next Year
- DXLG $3.56
- DTIL $30.20
- P/E Ratio
- DXLG N/A
- DTIL N/A
- Revenue Growth
- DXLG N/A
- DTIL N/A
- 52 Week Low
- DXLG $0.90
- DTIL $3.61
- 52 Week High
- DXLG $3.93
- DTIL $11.09
- Technical
- Relative Strength Index (RSI)
- DXLG 43.76
- DTIL 44.86
- Support Level
- DXLG $1.00
- DTIL $4.20
- Resistance Level
- DXLG $1.16
- DTIL $5.29
- Average True Range (ATR)
- DXLG 0.08
- DTIL 0.36
- MACD
- DXLG -0.01
- DTIL -0.03
- Stochastic Oscillator
- DXLG 15.52
- DTIL 36.88
About DXLG Destination XL Group Inc.
Destination XL Group Inc is a retailer of branded and Tall men's clothing and shoes in the United States. It also sells products across the world. The company sells its products under the trade names Destination XL, DXL, DXL Men's Apparel, DXL outlets, Casual Male XL, and Casual Male XL outlets. The company has two principal operating segments: Store, and Direct business.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.